2012 Annual Meeting | Clinical Research Colloquium

Date Sunday 04/22/12

Time 02:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Colloquium

Director(s) Walter A. Rocca, MD, MPH

Topic(s)

Learning Objectives Participants should improve their ability to design, conduct, and interpret clinical studies, and to write and read scientific papers and grant applications.

CME Available No CME available

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic

Program Evaluations

Event Timeline
02:00 PM - 02:45 PM		Introduction to Study Design Walter A. Rocca, MD, MPH
02:45 PM - 02:55 PM		Questions and Answers
02:55 PM - 03:40 PM		Clinical Trial Designs: Learning and Confirming Karl D. Kieburtz, MD
03:40 PM - 03:50 PM		Questions and Answers
03:50 PM - 04:10 PM		Break
04:10 PM - 04:55 PM		Cohort Studies Stephen K. Van Den Eeden, PhD
04:55 PM - 05:05 PM		Questions and Answers
05:05 PM - 05:50 PM		Case-control Studies Walter A. Rocca, MD, MPH
05:50 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
Walter A. Rocca, MD, MPH	The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Karl D. Kieburtz, MD	Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Stephen K. Van Den Eeden, PhD	Dr. Van Den Eeden has received personal compensation for serving as an employee of Kaiser Permanente Northern California. The institution of Dr. Van Den Eeden has received research support from NIH. The institution of Dr. Van Den Eeden has received research support from Biogen. The institution of Dr. Van Den Eeden has received research support from MJFF. The institution of an immediate family member of Dr. Van Den Eeden has received research support from NIH.

��ɫ��

��ɫ��